(PharmaNewsWire.Com, April 04, 2017 ) A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures) , related derivatives (RNA, DNA, or proteins) , and cells.
Publisher's analysts forecast the global biobanking market to grow at a CAGR of 8.84% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global biobanking market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biobanking.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Biobanking Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
